ES2127948T3
2'-amido and 2'-peptido modified oligonucleotides
Abstract
AN OLIGONUCLEOTIDE IS PRESENTED, WHICH INCLUDES A NUCLEOTIDE BASE THAT HAS FORMULA (I) WHERE B IS A NUCLEOTIDE OR HYDROGEN BASE; R1 AND R2 ARE SELECTED INDEPENDENTLY BETWEEN THE GROUP THAT CONSISTS OF HYDROGEN, A GROUP OF RENT THAT CONTAINS BETWEEN 2 AND 10 ATOMS OF CARBON, BOTH INCLUDING, ONE AMINO, ONE AMINO ACID, AND ONE PEPTIDE THAT CONTAINS BETWEEN 2 AND 5 AMINO ACIDS , AND THE ZIG-ZAG LINES ARE INDEPENDENTLY HYDROGEN OR A LINK.
Term
Term ended
Projected expiry passed 24 October 2014, 11.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1,291 members in 26 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 14383293 | United States of America | A | |
| 14383293 | United States of America | A | |
| 19930143832 | United States of America | – | |
| 143832 | – | – | – |
| US19930143832 | – | – | – |
Members1,291
| Document | Office | Kind | |
|---|---|---|---|
| US828514A | United States of America | A | |
| CA2135499A1 | Canada | A1 | |
| CA2135646A1 | Canada | A1 | |
| WO9323057A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9323569A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4222993A | Australia | A | |
| AU4248993A | Australia | A | |
| CA2140343A1 | Canada | A1 | |
| WO9402595A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4769893A | Australia | A | |
| MX9302808A | Mexico | A | |
| MX9304329A | Mexico | A | |
| MX9302726A | Mexico | A | |
| CA2168566A1 | Canada | A1 | |
| WO9504818A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7375594A | Australia | A | |
| EP0641212A1 | European Patent Office (EPO) | A1 | |
| CA2169645A1 | Canada | A1 | |
| WO9506731A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP0642589A1 | European Patent Office (EPO) | A1 | |
| AU1457195A | Australia | A | |
| CA2174339A1 | Canada | A1 | |
| WO9511910A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2175824A1 | Canada | A1 | |
| CA2176035A1 | Canada | A1 | |
| WO9513378A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9513380A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU8088694A | Australia | A | |
| EP0654077A1 | European Patent Office (EPO) | A1 | |
| AU1090495A | Australia | A | |
| AU1097395A | Australia | A | |
| AU1821495A | Australia | A | |
| WO9513380A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO9506731A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2180740A1 | Canada | A1 | |
| WO9519429A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1566595A | Australia | A | |
| CA2183992A1 | Canada | A1 | |
| CA2468048A1 | Canada | A1 | |
| WO9523225A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9519429A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JPH07509133A | Japan | A | |
| CA2190513A1 | Canada | A1 | |
| WO9531541A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2642295A | Australia | A | |
| JPH08500481A | Japan | A | |
| WO9523225A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5496698A | United States of America | A | |
| EP0654077A4 | European Patent Office (EPO) | A4 | |
| JPH08502950A | Japan | A | |
| WO9531541A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5525468A | United States of America | A | |
| EP0716693A1 | European Patent Office (EPO) | A1 | |
| CA2207593A1 | Canada | A1 | |
| WO9618736A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4412096A | Australia | A | |
| EP0725788A1 | European Patent Office (EPO) | A1 | |
| EP0728204A1 | European Patent Office (EPO) | A1 | |
| EP0728205A1 | European Patent Office (EPO) | A1 | |
| WO9618736A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0737247A1 | European Patent Office (EPO) | A1 | |
| EP0746614A1 | European Patent Office (EPO) | A1 | |
| EP0748382A1 | European Patent Office (EPO) | A1 | |
| US5599704A | United States of America | A | |
| JPH09501318A | Japan | A | |
| JPH09502092A | Japan | A | |
| US5610052A | United States of America | A | |
| US5610054A | United States of America | A | |
| US5612215A | United States of America | A | |
| EP0763106A1 | European Patent Office (EPO) | A1 | |
| US5616488A | United States of America | A | |
| US5616490A | United States of America | A | |
| US5622854A | United States of America | A | |
| JPH09504297A | Japan | A | |
| MX9603638A | Mexico | A | |
| CA2235368A1 | Canada | A1 | |
| WO9715662A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US5627053A | United States of America | A | |
| JPH09504701A | Japan | A | |
| AU7666296A | Australia | A | |
| JPH09504949A | Japan | A | |
| US5631359A | United States of America | A | |
| US5631360A | United States of America | A | |
| EP0641212A4 | European Patent Office (EPO) | A4 | |
| EP0642589A4 | European Patent Office (EPO) | A4 | |
| US5639647A | United States of America | A | |
| US5639655A | United States of America | A | |
| US5646020A | United States of America | A | |
| US5646042A | United States of America | A | |
| WO9715662A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0786522A2 | European Patent Office (EPO) | A2 | |
| JPH09508018A | Japan | A | |
| US5658780A | United States of America | A | |
| EP0786522A3 | European Patent Office (EPO) | A3 | |
| MX9406022A | Mexico | A | |
| JPH09509323A | Japan | A | |
| US5672501A | United States of America | A | |
| US5672511A | United States of America | A | |
| EP0799313A2 | European Patent Office (EPO) | A2 | |
| MX9704440A | Mexico | A |
Showing 100 of 1,291
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Definitive protectionFG2A | FG2A |
Numbers
- Publication
- 2127948
- Publication, DOCDB
- 2127948
- Publication, EPODOC
- ES2127948T
- Application
- 94932003
- Application, DOCDB
- 94932003
- Application, EPODOC
- ES19940932003T
Titles2
- Spanish
- OLIGONUCLEOTIDOS MODIFICADOS EN LA POSICION 2'-AMIDO Y 2'-PEPTIDO.
- English
- OLIGONUCLEOTIDES MODIFIED IN THE POSITION 2'-AMIDO AND 2'-PEPTIDE.
Classification
- CPC, 26
- C12N15/113
- A61K38/00
- A61K48/00
- C07H21/00
- C12N15/101
- C12N15/1131
- C12N15/1136
- C12N15/1138
- C12N2310/111
- C12N2310/121
- C12N2310/122
- C12N2310/123
- C12N2310/1241
- C12N2310/126
- C12N2310/127
- C12N2310/32
- C12N2310/322
- C12N2310/333
- C12N2310/334
- C12N2310/335
- C12N2310/336
- C12N2310/3513
- C12N2310/3523
- C12N2310/3527
- C12N2310/3533
- C12N2310/3535
- IPC, 8
- C07H19 06
- A61K38 00
- A61K48 00
- C07H19 16
- C07H21 00
- C07K5 00
- C12N15 10
- C12N15 113